Results from a packed slate of clinical trials will provide new insights into the prevention and treatment of stroke.

A 2026 informational overview of ProvaDent's oral probiotic formulation, BioFresh™ enzyme complex, dental sugar hack positioning, disclosed ingredient research, and what to know before ordering ...

Tuberculosis (TB) remains one of the world's most serious public health threats, with approximately one-quarter of the global population infected with Mycobacterium tuberculosis. While most infections ...

This medication is used to improve breathing and reduce the risk of lung infections in people with cystic fibrosis. It is used along with other treatments for this disease (such as chest physical ...

Findings demonstrate that by degrading neutrophil extracellular traps (NETs), DNase I not only facilitates increased T cell infiltration but also restores T cell functionality, paving the way for more ...

Acute ischemic stroke treatment typically involves tissue-type plasminogen activator (tPA) or tenecteplase, but about 50% of patients do not achieve successful reperfusion. The causes of tPA ...

New research has developed an immunotherapy for cancer by combining DNase I with CAR T-cell therapy. The research conducted by Xenetic Biosciences titled, "The synergistic action of DNase I and CAR T ...

Xenetic (XBIO) Biosciences announced the presentation of preclinical data investigating the potential of co-administration of deoxyribonuclease I with chimeric antigen receptor T cells in a syngeneic ...

Systemic DNase I combined with 𝛼-CTLA-4 antibody demonstrated to promote antitumor immunity and generate immunological memory against microsatellite stable, mismatch repair proficient colorectal ...